2012
DOI: 10.1016/j.jevs.2012.08.128
|View full text |Cite
|
Sign up to set email alerts
|

Development of one-step TaqMan® real-time reverse transcription-PCR and conventional reverse transcription PCR assays for the detection of equine rhinitis A and B viruses

Abstract: been used to detect specific antibodies against the infections, but these assays are also restricted due to their antibody-detected limitation and/or potential cross-reactivity to other pathogens. For example, reading of IFAT results is very difficult to read results and not objective at borderline between positive and negative titers. Results of IFAT may also change not only with different origin of antigens, but also with different lots of FITC-conjugated anti-horse IgG antibody. Recently, new diagnostics su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…Nucleic acid from the remaining viruses was extracted using QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA, USA) as per the manufacturer's instructions. Before use in the FMDV RT‐iiPCR assay, the presence of viral RNA in each extraction was confirmed using published (Forsyth and Barrett, ; Tsunemitsu et al., ; Paton et al., ; Pasick et al., ; King et al., ; Deregt et al., ; Toussaint et al., ; Hindson et al., ; Lung et al., , ; Lu et al., ; Klima et al., ) or unpublished but laboratory‐validated (for PCV‐1) pathogen‐specific real‐time or conventional RT/PCR assays (data not shown).…”
Section: Methodsmentioning
confidence: 99%
“…Nucleic acid from the remaining viruses was extracted using QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA, USA) as per the manufacturer's instructions. Before use in the FMDV RT‐iiPCR assay, the presence of viral RNA in each extraction was confirmed using published (Forsyth and Barrett, ; Tsunemitsu et al., ; Paton et al., ; Pasick et al., ; King et al., ; Deregt et al., ; Toussaint et al., ; Hindson et al., ; Lung et al., , ; Lu et al., ; Klima et al., ) or unpublished but laboratory‐validated (for PCV‐1) pathogen‐specific real‐time or conventional RT/PCR assays (data not shown).…”
Section: Methodsmentioning
confidence: 99%